POPULARITY
Mike and Jack share an incredible listener-submitted story that's sure to make you smile. Sophia, a 39-year-old Type 1 diabetic from Portugal, recounts her hilarious and empowering experience at a nudist beach. With her insulin pump and CGM in plain view, Sophia's nerves turn into a chance for connection when she meets another T1D beachgoer. Plus, with her friend Diana's secret matchmaking, Sophia's day goes from awkward to heartwarming. This episode is all about embracing your diabetes devices, breaking down stigma, and finding unexpected connections—even on a nudist beach! If you're looking for funny T1D stories, real-life empowerment, and relatable moments, this episode is a must-listen. ------------------------------- Don't miss this episode filled with laughter, real talk, and the supportive stories that make the T1D community so special. Be sure to rate, review, and subscribe on Spotify, Apple Podcasts, or wherever you listen. Share the love and challenges with others in the T1D community! Follow The Podcast https://www.instagram.com/wearet1d Follow Mike https://www.instagram.com/t1d_mike Follow Jack https://www.instagram.com/t1d_jack Share your stories at https://wearet1d.com New episodes go out every Sunday & Wednesday! ------------------------------- Episode Highlights: 00:00 – Mike and Jack kick off the episode with banter and excitement. 00:47 – Introduction to Sophia's story: T1D on the Nudist Beach. 01:14 – T1D On A Nudist Beach Story 05:18 - Mike and Jack's Reaction
Recorded live at ADCES24, we sat down with Jane Jeffrie Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES, CDTC, FADCES to talk about the latest in diabetes technology and what to expect in the coming year, how diabetes technology overall is evolving and changing, and how diabetes technology can more seamlessly be integrated into primary care settings.Please note that this episode was recorded in August and some of the technology and updates discussed in future tense may now be in different stages of development or release. References to specific devices and manufacturers are for educational purposes and do not represent an endorsement from ADCES.Links: Register to view ADCES24 on-demand content: ADCES24 (adcesmeeting.org)Find up-to-date diabetes technology product information, device training, professional education and more on danatech: Diabetes technology for healthcare professionals | Danatech (adces.org)Find your technology competency level and resources to dive deeper with our tech competency tool: Technology Competency Finder| Danatech (adces.org)To learn more about the latest and greatest in diabetes technology, register for our Diabetes Technology Conference: Diabetes Technology Conference 2024 (eventscribe.net)To take a deeper dive into the integration of diabetes technology in primary care by checking out this two-part course developed in partnership with the American Association of Nurse Practitioners (Made possible thanks to a grant from Helmsley Charitable Trust).:Part 1: Integrating Diabetes Technology into Primary Care Part 1: Overview and Clinical Scenarios (0.75 CE/CME)Part 2: Integrating Diabetes Technology into Primary Care Part 2: Interactive Case Studies (1 CE/CME)Learn more about the PANTHER Program: Diabetes Technology. Deciphered. | PANTHER ProgramVisit diatribe: Making Sense of Diabetes | DiaTribeVisit the Medical Professional's Reference website: Prescription & OTC Drug Info | Side Effects, Interactions & Dosages (empr.com)Visit the ADA Consumer Guide: ADA Consumer Guide (diabetes.org)Find resources from DiabetesWise: Home » DiabetesWise Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Senseonics has received FDA clearance for a one-year continuous glucose monitoring system. The company's commercial partner, Ascensia, is in talks with insulin pump manufacturers to create an automated insulin delivery system. Zimmer is pulling its hip implant off the market due to fracture risk, Bausch + Lomb is considering a sale, and Masimo investor claims a proxy war win as CEO Joe Kiani fails to retain a board seat. The wearables market is expected to see significant growth, with adhesives playing a vital role in development. Other noteworthy stories include DermaSensor's skin cancer detection device, a Senate committee holding Steward CEO in contempt, and Medtronic detailing a study of adaptive neurostimulation in Parkinson's disease.Brisk Iced Tea brought back its classic claymation ad campaign featuring Doja Cat to target Gen Z. E.l.f. launched a skincare campaign with "Sinfluencer" Megan Stalter. Pizza Hut put resumes on boxes to help job seekers stand out. Frito-Lay used burner phones in a campaign targeting Gen Z for Flamin' Hot Cheetos. Chipotle planned a digital scavenger hunt to give out $1 million in free quesadillas. Customers' trust in AI is low, impacting purchasing decisions.Cigna is scaling back its Medicare Advantage footprint in 8 states next year, affecting roughly 5,400 members, mostly in Florida. Johnson & Johnson is facing sanctions over a plan to rebate 340B drugs, while Express Scripts is suing the FTC over a report criticizing pharmacy benefit managers. The US is behind other wealthy nations in healthcare despite spending the most, with a Commonwealth Fund analysis ranking the US last in access to care and health outcomes.Cigna is reducing its Medicare Advantage footprint in 8 states, affecting around 5,400 members, mainly in Florida. CarePoint Health may lay off 2,600 employees due to financial struggles. The House committee passed a bill to extend telehealth flexibilities in Medicare for another two years. Steward Health Care auctioned assets, with Christus Health set to purchase a Texas-based medical center for $4.5 million.MilliporeSigma is partnering with an experienced viral vector CDMO to offer solutions for the production of cell and gene therapies. They invite attendees of the Mesa conference in Phoenix to visit their booth or schedule a meeting to learn about their viral vector development and manufacturing capabilities.The Senate has voted to hold Steward CEO in contempt for defying a congressional subpoena. The US healthcare system lags behind other wealthy nations in performance despite spending the most. Oak Street Health pays $60 million to settle allegations of a kickback scheme, and J&J faces sanctions over a plan to rebate 340B drugs.Medtech news from September 19, 2024, includes updates on various companies and developments in the industry. Masimo's proxy fight is coming to an end, with a shareholder vote looming. Axonics wins a patent dispute against Medtronic, while Boston Scientific's proposal to buy Axonics is still under review.A startup from George Church's lab has raised $75 million to develop 'supercell' medicines, claiming it can create off-the-shelf therapies from induced pluripotent stem cells faster and simpler than current methods. Roche's Xofluza has shown promising results in reducing flu transmission in a phase 3 study, marking the first time an antiviral drug has achieved this in a global trial.The text discusses the latest advances in oncology research presented at the ESMO conference, focusing on the challenges faced by the pharmaceutical industry in expanding patient access and improving cancer research outcomes.The text promotes a webinar by QT Group on September 26th focusing on continuous compliance for medical software, specifically addressing how to maintain software quality and compliance with medical standa
Welcome to this midweek bonus episode of the We Are T1D podcast! This time, Mike takes the reins on the intro, bringing a fresh twist to our usual format. In this special episode, we dive into a delightful listener story titled "The Sugar Fairy Needs Saving" submitted by Alyssia. Join us as we explore her whimsical and heartwarming encounter at a theme park, where a young girl mistakes Alyssia for a sugar fairy due to her insulin pump and glucose tablets. Mike and Jack share laughs and insights as they navigate the charming tale, discussing the innocence of children and the unexpected moments that diabetes can bring. From managing sugar levels on the go to the magic of a child's imagination, this episode is sure to bring a smile to your face. 00:00 - Mike takes the intro 00:36 - How to submit a story 00:48 - Alyssia's story: The Sugar Fairy Needs Saving 03:46 - Reflections on the story 07:40 - Upcoming episode teasers & Outro Join the conversation and share your stories with the T1D community. Don't forget to rate, review, and subscribe to help others find the podcast. Follow The Podcast https://www.instagram.com/wearet1d Follow Mike https://www.instagram.com/t1d_mike Follow Jack https://www.instagram.com/t1d_jack Share your stories at https://wearet1d.com New episodes are released every Sunday & Wednesday PS. If you would like to be a guest on the podcast, please go to the website https://wearet1d.com/guest-booking and fill out the form. Stay tuned for more listener stories and community wins!
In this midweek bonus episode of the We Are T1D podcast, we dive into a listener's heartfelt story that is sure to resonate with many of our listeners. Becca, a young diabetic, shares her journey through her first day at secondary school, dealing with the challenges of managing type 1 diabetes while making new friends. Her candid and humorous recounting provides a glimpse into the bravery and resilience required to navigate school life with diabetes. Mike and Jack also celebrate the community's wins, featuring stories of personal achievements and milestones, from signing up for marathons to finding diabetes-friendly jobs. This episode is a testament to the strength and support within the T1D community. 00:00 - I've got to wake him up for this episode 00:16 - Midweek bonus is where we share one of your stories 00:46 - Whats the story 01:23 - Mike reads Becca's story 06:01 - Submit your stories 06:48 - Listener Wins 17:28 - Keep them wins and keep them stories coming in Join the conversation and share your stories with the T1D community. Don't forget to rate, review, and subscribe to help others find the podcast. Follow The Podcast https://www.instagram.com/wearet1d Follow Mike https://www.instagram.com/t1d_mike Follow Jack https://www.instagram.com/t1d_jack Share your stories at https://wearet1d.com New episodes are released every Sunday & Wednesday PS. If you would like to be a guest on the podcast, please go to the website https://wearet1d.com/guest-booking and fill out the form. PS. Ryan Taylor Part 2 Releasing: Sunday 18th August
The episode highlights Jack's success in managing a tricky meal, and addresses challenges like coping with hypos in the summer heat. Mike and Jack discuss culinary adventures and practical tips, from adjusting Lantus dosage to staying hydrated. Mike is off work this week and he has been busy!! Find out in this episode! Also about a free access card to places like Merlin's Thorpe Park. Listener stories, including better time-in-range percentages and switching to insulin pumps, demonstrate the diabetes community's resilience. Upcoming plans, like a trip to Thorpe Park, show their proactive approach to managing diabetes. This episode emphasizes community support and valuable insights into the highs and lows of living with type 1 diabetes. 00:00 - Intro 01:13 - Chit chat 01:25 - Jack's Wins and Struggles 06:40 - Mike's Wins and Struggles 08:16 - Get a free access pass for Merlin 09:35 - Come see us in London 12:31 - Whats your average 14:32 - Did somebody say Just Food? 25:39 - Listener Wins Join the conversation and share your stories with the T1D community. Don't forget to rate, review, and subscribe to help others find the podcast. Follow The Podcast https://www.instagram.com/wearet1d Follow Mike https://www.instagram.com/t1d_mike Follow Jack https://www.instagram.com/t1d_jack Share your stories at https://wearet1d.com New episodes are released every Sunday & Wednesday PS. If you would like to be a guest on the podcast, please go to the website https://wearet1d.com/guest-booking and fill out the form.
For those with diabetes who use insulin pump therapy, having access to training and education on this technology is key to success. David Jopke, DNP, FNP-C, BC-ADM, CDCES, Tracy Newell RD LD, CDCES, RD, LD, CDCES, Erin L. DaRosa, MBA, RDN, LD, CDCES join The Huddle to talk about their experiences creating a team-based formal process for becoming an insulin pump trainer, and how practice settings that want to offer insulin pumps and automated insulin delivery system options to people with diabetes can create their own formalized process.Learn more about HealthPartners here: HealthPartners – Top-Rated insurance and health care in Minnesota and WisconsinView danatech's resources on insulin pumps & AID here: Insulin Pumps l diabetes training and education l Danatech (adces.org)Learn more about the Panther program here: Diabetes Technology. Deciphered. | PANTHER Program Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.
Welcome to this episode of the Your Diabetes Insider podcast. It's summer, and today, we're diving into a topic close to every insulin-dependent, pump-using listener's heart: the insulin pump break! Whether you're lounging by the pool, hiking a mountain trail, or simply tired of doorknob mishaps, there are moments when ditching the pump feels liberating. But why take a break from such a life-saving device? Join us as we explore the practicalities and challenges of switching from a pump to multiple daily injections (MDI). We'll discuss the convenience of pumps versus the freedom of MDI, sharing personal anecdotes and practical tips. From managing basal insulin with long-acting analogs to calculating boluses without a pump's algorithmic help, there's a lot to consider. And let's not forget the importance of always having a backup plan, especially when technology fails or situations demand unplugged simplicity. Join us for a candid conversation about the highs and lows (literally!) of life without an insulin pump. Whether you're new to diabetes management or a seasoned veteran, this episode offers insights that could make a world of difference in your daily diabetes care routine. RESOURCES: Download these FREE guides that will help you on your diabetes, nutrition, and exercise journey! https://www.yourdiabetesinsider.com/free-stuff Join our EXCLUSIVE Facebook group! https://www.facebook.com/groups/266766620895432 Watch my food breakdowns here → https://www.youtube.com/@yourdiabetesinsider LET'S TALK! Instagram: @manoftzeel Tiktok: @manoftzeel Want the best blood sugars you've ever had while enjoying great food? Peep this: https://www.yourdiabetesinsider.com/coaching
We start with some classic outtakes, including a hilarious debate on how to pronounce HbA1c. Is it Hab one c or HBA one c? We finally get there in the end, but not without a lot of laughs. Our outtakes also feature some classic banter about blood sugar levels, annoying family members, and the joys of dynamic mics. We even touch on the absurdity of calling your HbA1c anything other than your average. What's your average, bruv? Next, we dive into this week's listener story. It's a bit naughty, so if you're a child, maybe skip this one. Our anonymous listener shares their experience of starting an OnlyFans during lockdown. The story takes a hilarious turn when a subscriber mistakes their insulin pump for a new type of vibrator. The listener plays along, leading to some very funny misunderstandings. This episode is packed with laughs, relatable moments, and a reminder that we all deal with ignorance about our chronic condition. For more T1D content and to share your own stories, follow the podcast on Instagram at https://www.instagram.com/wearet1d and visit the website at https://wearet1d.com. Remember, laughter is the best medicine—along with insulin! Until next time, keep those blood sugars steady and your spirits high!
Alison Smart has a teenage daughter who was diagnosed with type 1 diabetes almost three years ago. Her family found that lifestyle modifications, dietary changes and a regimen of daily injections utilizing the basal insulin Levemir enabled her daughter to achieve excellent blood glucose results! Alison's daughter is an athlete who experiences a typical teenage life with little disruption from diabetes. However, in November of 2023 Novo Nordisk announced Levemir insulin would be discontinued. This announcement came just months after Novo Nordisk announced they would significantly decrease the price of this insulin. Alison got to work and joined with others who are also incredulous at the thought of being left with only the option of two other basal insulins or an insulin pump. They created the Alliance to Protect Insulin Choice, started a petition on change.org, compiled a YT video of testimonials, and met with several senators and congressional representatives in Washington DC. They continue to move forward with their goal of pressuring Novo Nordisk to slow down the discontinuation and produce Levemir until a biosimilar basal insulin is available.Find Alison at-FB- @Alliance to Protect Insulin ChoiceTW- @insulinchoiceIG- @alliancetoprotectinsulinchoiceinsulinchoice@gmail.comFox News ArticleFind Boundless Body at- myboundlessbody.com Book a session with us here!
Paul Edick and Sean Saint are CEOs of thier respective companies (Beta Bionics and Xeris). Today we talk about their new relationship and their desire to create a bi-hormonal insulin pump. Learn about the Dexcom G6 and G7 CGM Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED or call 888-721-1514 Learn about Touched By Type 1 Take the T1DExchange survey Free 14 Day Trial of Aura Eversense CGM Learn about the Medtronic Champions This BetterHelp link saves 10% on your first month of therapy Try delicious AG1 - Drink AG1.com/Juicebox Use code JUICEBOX to save 40% at Cozy Earth CONTOUR NextGen smart meter and CONTOUR DIABETES app *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof. A full list of our sponsors How to listen, disclaimer and more Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. If the podcast has helped you to live better with type 1 please tell someone else how to find the show and consider leaving a rating and review on Apple Podcasts. Thank you! The Juicebox Podcast is not a charitable organization.
In this episode of Diabetics doing things, Rob interviews Paul Edick from Xeris Biopharma and Sean Saint from Beta Bionics. They discuss the formal partnership announcement between Xeris Biopharma and Beta Bionics, focusing on the development of a bi-hormonal insulin pump for diabetes management. The conversation touches on the challenges and benefits of the partnership, the development process, and the potential impact on diabetes care. Topics discussed: 1. Partnership between Xeris Biopharma and Beta Bionics 2. The unique challenges faced by a bihormonal pump compared to traditional insulin pumps. 3. The formulation process of the pump and collaboration between Xeris and Beta Bionics. 4. The upcoming phase 2 and phase 3 clinical trials. 5. The importance of glucagon in diabetes management and the need for increased awareness and availability of glucagon. 6. The potential for a fully automated diabetes therapy experience. 7. The role of technology in reducing the burden of diabetes management and enhancing quality of life. 8. The journey towards regulatory approval and commercialization. 9. The historical context of glucagon use and the evolving perceptions around its importance. 10. The positive impact of the partnership on advancing diabetes care and glycemic control. Key takeaways: * The partnership between Xeris Biopharma and Beta Bionics aims to develop a bihormonal pump for diabetes management. * The collaboration involves overcoming unique challenges associated with incorporating both insulin and glucagon in the pump. * The development process includes formulation, clinical trials, and regulatory approval. * The partnership highlights the importance of increasing awareness and availability of glucagon for diabetes patients. * The ultimate goal is to provide a hands-off, automated diabetes therapy experience to improve quality of life for individuals with diabetes. References: * Xeris Biopharma * Beta Bionics 00:00 Exploring Inspiring Stories of People with Diabetes and Industry Announcements 00:18 Exciting Partnership Announcement: Xeris Biopharma and Beta Bionics Join Forces for Innovative Diabetes Solution 03:58 Revolutionizing Diabetes Care with Biohormonal Pump and Xerasol Technology 08:52 Exploring the Future of Glucagon Use and Reducing Stigma in Diabetes Management 13:41 Revolutionizing Diabetes Therapy: The Future of Automated Insulin and Glucagon Pump Systems 23:41 Overcoming Fear and Stigma: The Journey with Glucagon and the Future of Insulin Pumps 25:17 Challenges and Partnerships in Developing a Bi-Hormonal Pump for Diabetes Management 30:47 Exciting Innovations in Diabetes Care: A Look into Bi Hormonal Pumps
Reliability of COVID-19 tests unreliable; Insulin pump app updated following battery issue; Noninvasive colorectal cancer test gets FDA approval; Self-collection HPV screening option; National Drug Threat Assessment highlights illicit drugs currently endangering the US.
Warning: This episode is not for the faint of heart or those easily offended. It's raw, it's real, and it's a bit naughty. You've been warned. Brace yourselves for the long-awaited and unabashed Part Two of the Jonsel episode on 'We Are T1D' - the podcast that doesn't just talk diabetes, it lives it. Hosts Mike and Jack, the candid voices of Type 1 Diabetes, delve into the gritty, unpolished side of living with T1D, with their guest who's as real as it gets. Jonsel, a man who's not afraid to speak his truth, shares his journey through the entertainment industry, his battle with the highs and lows of diabetes, and the stark reality of managing this chronic condition in the public eye. From the heartache of empty theatres to the frustration with charities, Jonsel's story is a rollercoaster of emotions and experiences that many with T1D can relate to. Get ready for some outrageous hypo tales that will have you in stitches, discussions on the taboo topic of diabetes and sex, and the kind of uproarious banter that only comes from three guys who know how to laugh in the face of adversity And for those who've been touched by Jon's candidness, his books, 'Diabetes Won't Defeat Us' and 'Keep Calm I'm Only Diabetic', are available on Amazon. Plus, don't miss his powerful short film, 'Hypo', on YouTube - a must-watch that sheds light on the silent struggles of living with T1D. Follow Jonsel on Instagram @jonsel99 and join the conversation that's breaking barriers and building bridges in the T1D community. Remember to Subscribe/Follow, Rate, and Review to support the podcast and help spread the word about the real life of living with Type 1 Diabetes. Share your stories, find your tribe, and never forget - you're not alone on this ride. Until next time, keep it real, keep it raw, and keep laughing through the lows. Peace out, and stay syringed! Follow The Podcast https://www.instagram.com/wearet1d Follow Mike https://www.instagram.com/t1d_mike Follow Jack https://www.instagram.com/t1d_jack Get your wins on the podcast at https://wearet1d.com
This week, the newest pump coming to the market is called the twiist. It's a very different shape – circular with a top half that twists off – with very different software – Tidepool Loop. The company behind this pump – they're called Sequel - wants to be different as well, hoping to offer solutions to bigger issue than basal and bolus rates. It's very ambitious and we have a wide ranging conversation about it all with Sequel's CEO Alan Lotvin This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Our episode about Tidepool Loop approval Find out more about Moms' Night Out Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com Reach out with questions or comments: info@diabetes-connections.com
I spoke with Sequel Med Tech about its newly FDA cleared insulin pump, twiist. We cover the history of Sequel Med Tech, all the details on the brand new tubed pump, how it's worn and what it looks like, and how the DIY community impacted the development and more. Get Skin Grip patches (10% off w/ JUSTIN10) Thanks to our sponsor, Skin Grip. Code won't combine with other promos. Fill out T1D Exchange Registry Join Patreon for Exclusive Content | Join Diabetech Community Discord Learn More About Twiist and Sequel Med Tech Follow for more: Instagram | Tik Tok | YouTube | Facebook Send us Feedback & Join the Newsletter DISCLAIMER: This podcast is not medical advice. Always consult with your doctor before making changes to your health care.
Summary In this episode, Evan and Jonathan are joined by Ellie White to discuss the accessibility of medical devices, specifically insulin pumps and glucose monitors. Ellie shares her experience managing type 1 diabetes and the challenges she faces with the current lack of accessibility in these devices. They also discuss the importance of advocacy and legislation to improve accessibility in medical devices. The conversation concludes with a fun segment on the Sandwich of the Week. Takeaways Medical devices such as insulin pumps and glucose monitors often lack accessibility features, making it difficult for individuals with visual impairments to manage their conditions. Advocacy and legislation, such as the Medical Device Non-Visual Accessibility Act, are crucial in pushing for improved accessibility in medical devices. Ideally, accessible medical devices should have standalone features with tactile buttons or voice prompts, rather than relying solely on smartphone apps. The accessibility of medical devices can greatly impact the quality of life for individuals with visual impairments, and it is important for manufacturers to prioritize inclusivity. Chapters 00:00 Introduction and Easter Sunday 03:12 Discussion on Medical Devices and Accessibility 06:29 Ellie's Medical Devices 07:51 Accessibility of Insulin Pump 10:55 Accessibility of Dexcom Monitor 13:56 Advocacy for Accessibility in Medical Devices 16:24 Ideal Accessibility Features 20:09 Contact Information and Closing Remarks
My guest on the show today is James (Jeb) Besser, CEO of Modular Medical, Inc. (NASDAQ: MODD). Modular Medical, Inc. (Nasdaq:MODD) is a development-stage medical device company that is working towards launching the next generation of insulin delivery technology. Using its patented technologies, the company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. As Jeb discusses in the interview, despite many tech companies trying to find "next generation" solutions for an insulin pump, it's only been recently that there's been some momentum in the delivery technology itself vs. a smart phone-related monitoring solution. That is why I invited Jeb on today to discuss the following: The history of insulin pump innovation Why patients the standard of care pump is so complicated Modular Medical's delivery technology and what makes it unique; and, Next steps for commercialization For more information about Modular Medical, please visit: https://modular-medical.com/ This podcast was recorded and is being made available by SNN, Inc. (together with its affiliates and its and their employees, “SNN”) solely for informational purposes. SNN is not providing or undertaking to provide any financial, economic, legal, accounting, tax, or other advice in or by virtue of this podcast. The information, statements, comments, views, and opinions provided in this podcast are general in nature, and such information, statements, comments, views, and opinions, and the viewing of/listening to this podcast are not intended to be and should not be construed as the provision of investment advice by SNN. The information, statements, comments, views, and opinions expressed in this podcast do not constitute and should not be construed as an offer to buy or sell any securities or to make or consider any investment or other course of action. The information, statements, comments, views, and opinions expressed in this podcast (including by guest speakers who are not officers, employees, or agents of SNN) are not necessarily those of SNN and may not be current. Reference to any specific third-party entity, product, service, materials, or content does not constitute an endorsement or recommendation by the SNN. SNN assumes no responsibility or liability for the accuracy or completeness of the content contained in third party materials or on third party sites referenced in this podcast or the compliance with applicable laws of such materials and/or links referenced herein. The views expressed by guest speakers are their own and their appearance on this podcast does not imply an endorsement of them or any entity they represent. SNN does not make any representation or warranty as to the accuracy or completeness of any of the information, statements, comments, views, or opinions contained in this podcast, which may include forward-looking statements where actual results may differ materially. SNN does not undertake any obligation whatsoever to provide any form of update, amendment, change, or correction to any of the information, statements, comments, views or opinions set forth in this podcast. SNN EXPRESSLY DISCLAIMS ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR OTHER DAMAGES ARISING OUT OF ANY INDIVIDUAL'S USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE, THIS PODCAST OR THE INFORMATION PRESENTED IN THIS PODCAST. By accessing this podcast, the listener acknowledges that the entire contents and design of this podcast, are the property of SNN, or used by SNN with permission, and are protected under U.S. and international copyright and trademark laws. Except as otherwise provided herein, users of this podcast may save and use information contained in the podcast only for personal or other non-commercial educational purposes. No other use, including without limitation, reproduction, retransmission, or editing of this podcast may be made without the prior written consent of SNN.
This episode walks through all of the automated insulin pumps currently available in the U.S - the iLet from Beta Bionics, Omnipod, Tandem's tslim X2 and Mobi, and the Medtronic 780g. We cover algorithm and setup, water resistance, cgm support, which is best for who, and how cost and warranties work. Gary's Practice Gary's Book Think Like a Pancreas DISCLAIMER: This podcast is not medical advice. Always consult with your doctor before making changes to your health care. Fill out T1D Exchange Registry Follow for more: Instagram | Tik Tok | YouTube | Facebook Watch Video Podcast on Youtube
Jo Cheah and endocrinologist Benjamin Sly discuss devices for self-monitoring blood glucose concentrations. The conversation covers both capillary (fingerprick) monitoring and continuous blood glucose monitoring, the types of monitoring devices available to patients and their different features. Ben explains how to select the most appropriate device. Read the full article by Benjamin Sly and his co-author Janet Taylor in Australian Prescriber.
In this new podcast episode, Ben shares his expertise on troubleshooting insulin pump challenges, addressing issues with sites, and the frustration of questioning whether the site is working. From recognizing problematic sites to practical tips on rotation and scar tissue management, Ben provides valuable insights for both pump users and those considering the switch. Whether you're a seasoned pump user or exploring insulin options, this episode is packed with essential information to empower you on your diabetes journey. Don't miss this candid discussion that goes beyond the basics, offering real-world solutions and personal experiences to help you achieve amazing blood sugars and live life without restriction from diabetes. Tune in now for an engaging and informative episode that could transform your approach to insulin pump management! RESOURCES: Download these FREE guides that will help you on your diabetes, nutrition and exercise journey! https://www.yourdiabetesinsider.com/free-stuff Join our EXCLUSIVE Facebook group! https://www.facebook.com/groups/266766620895432 Watch my food breakdowns here → https://www.youtube.com/@yourdiabetesinsider LET'S TALK! Instagram: @manoftzeel Tiktok: @manoftzeel Want the best blood sugars you've ever had while enjoying great food? Peep this: https://www.yourdiabetesinsider.com/coaching
In season 10 episode 4, Emily and Christie talk where to place insulin pumps and do multiple daily injections (MDI) in colder weather, as well as how to manage dry itchy skin with diabetes. Hosted on Acast. See acast.com/privacy for more information.
In season 10 episode 4, Emily and Christie talk where to place insulin pumps and do multiple daily injections (MDI) in colder weather, as well as how to manage dry itchy skin with diabetes. Hosted on Acast. See acast.com/privacy for more information.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here's what you need to know for today, September 12, 2023. [Check out the show notes for links to the stories we discuss today at MassDevice.com/podcast.] Zeta Surgical recently announced it won FDA clearance for its mixed reality cranial surgical navigation system. Fast Five hosts Sean Whooley and Danielle Kirsh explain what the navigation system is and how it assists surgeons. Centinel Spine announced last week that it is divesting its spine fusion business. Find out what the sale means for the company, when the deal will close and what executives think about this strategic move. Surgical robotics are in the news again. Quantum Surgical won CE mark approval for its surgical robot that treats lung tumors. Whooley explains the purpose of the robot and what the expanded approval follows. Philips has launched a new ultrasound technology to assist with cancer diagnostics. Learn what the technology does and why it is important for clinicians and patients. Analysts think that GLP-1 drugs may have a minor impact on the insulin pump market but could boost the use of continuous glucose monitors. Whooley details what the impact could be and what analysts think about the impact of this class of pharmaceuticals on the insulin delivery market.
In this episode, Ayesha talked about the FDA clearance of the world's smallest insulin pump from Tandem Diabetes Care. The insulin pump, called the Tandem Mobi, features an automated insulin delivery system with options for manual delivery as well. The device is small enough to fit into the coin pocket of a pair of jeans and offers several wearable options. It can be operated through an app and also features technology compatible with continuous glucose monitoring systems. Ayesha and the team also discussed the FDA clearance of the first FDA cleared NMR-based test from Numares Health. The company's AXINON test system measures levels of low density lipoprotein particle (LDL-p), which the company touts as being a more robust biomarker than LDL-cholesterol (LDL-c) for evaluating cardiovascular disease risk. Hear more about the test, including some of its other disease applications, in this episode. Read the full articles here:Tandem Mobi Becomes World's Smallest Insulin Pump with FDA ClearanceNew Cardiac Biomarker Test Gets FDA ClearanceFor more life science and medical device content, visit the Xtalks Vitals homepage.Follow Us on Social MediaTwitter: @Xtalks Instagram: @Xtalks Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured
Tandem's new insulin pump coming later this year is the world's smallest durable pump. Gary Scheiner and I breakdown all there is to know about the new pump. Follow for more: Instagram | Tik Tok | YouTube | Facebook Watch Video Podcast on Youtube This podcast should NOT be considered medical advice. Always consult with your doctor before making changes to health care treatment.
Drew Harrisberg is an Exercise Physiologist, Sports Scientist and holds a Graduate Certificate in Diabetes Education and Management. – But most importantly Drew is a healthy and happy guy thriving with type 1 diabetes. At the age of 22 Drew was diagnosed with type 1 diabetes. After an incredibly frightening introduction to his journey with the autoimmune condition, Drew has championed diabetes within his life as a window into the remarkable impacts of regular exercise an good nutrition.Not only from a personal perspective, but also in terms of his education and how he can add value to the lives of others living with diabetes. As an ambassador for Diabetes Australia, Drew is remarkably optimistic and positive about what his diagnosis means to him. Believing that he is now healthier, and will likely be free of other health complications that he would have faced without the day-to-day, hour-to-hour insight that diabetes has provided him.Research from Stanford University in 2014 found that People living with diabetes make an extra 180 health related decisions each and every day..to put that in perspective it's about one additional decision every 5 minutes, or an extra 12 decisions every waking hour related to considerations like alerts from insulin pumps or CGM devices, blood glucose checks, insulin adjustments and carbohydrate intake.It is no surprise that 1 in 5 people living with the condition experience anxiety or depression.Subsequently drew has since made it his mission to control his health through positive changes to the way he thinks, eats, moves and lives his life.Any information or anecdotes related to diet or pharmaceutical management of diabetes discussed within this episode should be taken more broadly in nature. If you or someone you know is living with diabetes, please encourage them to consult with a Accredited Practicing Dietitian (APD) and Credentialled Diabetes Educator (CDE) before embarking on a major insulin or dietary adjustments. ________________ReferencesPMID31211392 - Toghi-Eshghi et al. (2019). Morning (Fasting) vs Afternoon Resistance Exercise in Individuals With Type 1 Diabetes: A Randomized Crossover Study.PMID23418444 - Duviver et al. (2013). Minimal intensity physical activity (standing and walking) of longer duration improves insulin action and plasma lipids more than shorter periods of moderate to vigorous exercise (cycling) in sedentary subjects when energy expenditure is comparable.PMID22374636 - Dunstan et al. (2012). Breaking up prolonged sitting reduces postprandial glucose and insulin responses.PMID34009435 - Moholdt et al. (2021). The effect of morning vs evening exercise training on glycaemic control and serum metabolites in overweight/obese men: a randomised trial.PMID22218619 - Matheson et al. (2012). Healthy lifestyle habits and mortality in overweight and obese individuals.________________Drew's linksInstagram: @drews.daily.doseDrew's Daily Dose: www.drewsdailydose.com________________Follow us on social media!Instagram: @normlesspodcast YouTube: www.youtube.com/@normlessFacebook: www.facebook.com/normlesspodcast/ LinkedIn: https://www.linkedin.com/company/norm...TikTok: https://www.tiktok.com/@normlesspodcastWebsite: normlesspodcast.simplecast.com________________Hayden Kelly, ESSAM, AES, AEP, MHPSHost of the NORMLESS podcastConnect with me on Instagram, Twitter, Facebook and LinkedIn ________________Want to support the show?The best way to show your support is by providing a review on the Apple Podcast app, Spotify or via our facebook page.You can also stay in the loop with the latest podcast updates, news and information by subscribing to our mailing list.
Each month, I reflect on my biggest wins, learnings, and challenges over the past 30 days with type 1 diabetes. Come along for the ride as I give you a recap of the highs and lows of my diabetes management in July 2023! Sign up now to get your FREE daily T1D + Mental Health tip! www.thediabetespsychologist.com/tip Diabetes Sucks and You Can Handle It can now be purchased on my website, www.thediabetespsychologist.com/book. Follow The Diabetes Psychologist on Instagram @thediabetespsychologist and join The Diabetes Psychologist Community on Facebook.
An oldie but a goodie! Back in episode 69, we highlighted the top 3 insulin pump manufacturers, the features of each pump, and what was possibly in the pipeline (as we knew then).The info in this episode is still relevant especially with so many new diagnoses, and especially since many doctors offices and endocrine clinics have financial relationships with Medtronic... which means T1Ds might not even know about the other insulin pump options out there.Like anything with your T1D care, the insulin pump you choose should be an informed decision, and not one that you get strong-armed into. For some, MDI works better. For others, Omnipod. That's what it comes down to: the freedom to CHOOSE.So take a listen to this MVP episode on the different kinds of pumps out there.Join the Half-Dead Pancreas Club! What to do next... Leave a review on Apple Podcasts Join the Half-Dead Pancreas Club Follow the Pod on Instagram Follow Colleen on Instagram Follow Jessie on Instagram Follow us on TikTok
This week, Dr. Michael Paddock answers some common insulin and diabetes management questions we have all had. Don't miss out! Follow HERE!Support the showFind ER-Rx: - On Instagram: @ERRxPodcast - On the website: errxpodcast.com - On YouTube Disclaimer: The information contained within the ER-Rx podcast episodes, errxpodcast.com, and the @errxpodcast Instagram page is for informational/ educational purposes only, is not meant to replace professional medical judgement, and does not constitute a provider-patient relationship between you and the authors. Information contained herein may be accidentally inaccurate, incomplete, or outdated, and users are to use caution, seek medical advice from a licensed physician, and consult available resources prior to any medical decision making. The contributors of the ER-Rx podcast are not affiliated with, nor do they speak on behalf of, any medical institutions, educational facilities, or other healthcare programs.
Layoffs are becoming a common occurrence in the medical device industry, and they can be a result of various factors. Fast Five hosts Danielle Kirsh and Sean Whooley explore 3M's latest layoff and what the company hopes to do in its restructuring efforts. Insulin pumps are a crucial medical device for people living with diabetes. Insulet, one of the major diabetes device companies in the industry, recently won FDA clearance for its Omnipod GO. Whooley discusses what that means for diabetes patients and when they can expect to see the device on the market. Proprio recently won FDA clearance for its orthopedic surgical navigation platform. It is reported that the system is projected to improve orthopedic procedures and help surgeons more accurately place pedicle screws. The Fast Five hosts discuss how the system works and how executives feel about the company's innovations to come. Life support devices are important for sustaining patients, and the demand for the devices was unprecedented during the COVID-19 pandemic. This week, Abbott received a pair of FDA clearances for its CentriMag life support system. Whooley explains what the FDA indications cover and how the systems work. Stroke treatment devices have revolutionized stroke care in recent years. Whooley and Kirsh take a look at Route 92 Medical's newly FDA-cleared stroke treatment system and how physicians are liking the device so far. Read more at massdevice.com/podcast.
Originally posted on Jan 21,2021. The Juicebox Podcast: Type 1 Diabetes social media community sent their tips for switching from MDI to pumping. This BetterHelp link saves 10% on your first month of therapy Try delicious AG1 from Athletic Greens Use code JUICEBOX to save 35% at Cozy Earth Get the Gvoke HypoPen CONTOUR NEXTONE smart meter and CONTOUR DIABETES app Learn about the Dexcom G6 and G7 CGM Go tubeless with Omnipod 5 or Omnipod DASH Get your supplies from US MED or call 888-721-1514 Learn about Touched By Type 1 Take the T1DExchange survey A full list of our sponsors How to listen, disclaimer and more Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The show is now available as an Alexa skill. My type 1 diabetes parenting blog Arden's Day Listen to the Juicebox Podcast online Read my award winning memoir: Life Is Short, Laundry Is Eternal: Confessions of a Stay-At-Home Dad The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! Follow Scott on Social Media @ArdensDay @JuiceboxPodcast Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. If the podcast has helped you to live better with type 1 please tell someone else how to find the show and consider leaving a rating and review on iTunes. Thank you! Arden's Day and The Juicebox Podcast are not charitable organizations.
The pious month of Ramadan and Navratri has commenced and many people would observe fasting with food, without food and water (for limited hours). Approximately 80% of diabetics can observe safe fasting. International Diabetes Federation (IDF) has made global guidelines on Ramadan fasting for People with Diabetes (PWD), which should be followed during fasting. According to these guidelines, most of PWD can do fasting with precautions. Those who have Brittle Diabetes with lot of fluctuations of blood glucose should avoid fasting. PWD on many oral drugs or multiple doses of insulin should avoid fasting to prevent hypoglycemia, hyperglycemia or ketosis. Many T1 Diabetics (T1DM) are on Insulin Pump, where insulin doses can be adjusted as per the carbs in their meal, lifestyle and blood glucose. They must consult their treating Doctor before commencing any type of fast. Similarly, T2DM those who are on single or multiple drug combinations or on diet control should also consult their doctor before fasting. Few medicines like Biguanides (Metformin), Gliptins etc. are safer during fasting and have low risk of hypoglycemia. Those who are on insulin, the dose may need to be reduced to prevent hypoglycemia. PWD with associated complications like heart disease, brain stroke, kidney failure, retinopathy, Cancer etc. and those with history of any recent major surgery should avoid fasting. It is advisable to take a fitness certificate for fasting from your Doctor and practice smart fasting. While fasting, mild exercises like daily household work, walking, yoga & Pranayam can be incorporated, however we should avoid vigorous exercises. Women with diabetes in pregnancy should avoid fasting for a healthy fetal growth. Awareness about fasting should be created amongst the health care professionals, para medical staff and diabetes educators, so that they can counsel their PWD for safe fasting.
In this heartwarming episode, Ady opens up about her life as a Type 1 Diabetic and a Pilates instructor. She shares her story of facing embarrassment when she first learned of her condition and how she has come to embrace it with grace. Ady also speaks about the helpful tools she uses to manage her diabetes, such as the Dexcom wireless device and insulin pump. The conversation then turns to the delicate subject of Ady's struggles with an eating disorder and the importance of reaching out for help. Ady shares her personal relationship with God, which has provided her with strength and comfort throughout her journey. She encourages all listeners, especially young women, to not be afraid to ask for help and to always prioritize self-care. With empathy and gentleness, Ady inspires us all to be kind to ourselves and embrace our unique journeys.Follow Ady: @adymcgeeeFollow Tanya Here:InstagramFacebookTikTokYouTubeLinkedInTwitter
It's In the News, a look at the top stories from the diabetes community from the last seven days. This week: Tandem buys the maker of Sigi Pump, a reusable, rechargable patch pump, Lilly uncouples from Ypsomed, big study finds widespread adoption of insulin pumps among people with type 1, but not among people of color, a big look at vegetables studies and why potatoes are basically messing things up.. and a lot more! Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here Episode Transcription Below (or coming soon!) Please visit our Sponsors & Partners - they help make the show possible! *Click here to learn more about OMNIPOD* *Click here to learn more about AFREZZA* *Click here to learn more about DEXCOM* Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and these are the top diabetes stories and headlines of the past seven days. XX In the news is brought to you by T1D Exchange! T1D Exchange is a nonprofit organization dedicated to improving outcomes for the entire T1D population. https://t1dexchange.org/stacey/ XX Big new study about insulin pumps shows white patients are twice as likely to get one as Black patients, and better-educated, wealthier people are also more likely to be using one. Over 20 years, starting in 2001, these researchers saw a large increase in insulin pump use across all patients, but no change in distribution by race or socioeconomic status The study was recently published in the journal Diabetes Technology & Therapeutics. Recent data found that Black people had higher rates of severe diabetes-related complications compared with white folks. There is also a concern that these gaps will widen with the new automated insulin-delivery systems, worsening health inequality for subsets of youth with type 1 diabetes. https://www.usnews.com/news/health-news/articles/2022-12-13/insulin-pumps-ease-diabetes-care-so-why-are-black-patients-less-likely-to-get-one XX Tandem Diabetes snaps up a patch pump.. buying the Swiss company that makes Sigi. The Sigi Patch Pump is not yet available, it has FDA breakthrough designation. This is a rechargeable pump, you get two you can switch out, and the infusion set is disposable. It's set up to work with an AID system. We did an episode with SIGI earlier this year.. no word on what this might mean for Tandem's Mobi pump.. which is a tubed pump that's very small and was meant to compete with Omnipod.. before this news. https://www.businesswire.com/news/home/20221213005314/en/Tandem-Diabetes-Care-to-Acquire-Insulin-Patch-Pump-Developer-AMF-Medical XX Eli Lilly has pulled out of a partnership with Ypsomed that would have given it a branded insulin pump to sell in the U.S. Lilly struck a deal two years ago to commercialize YpsoPump under its own brand in the U.S. The partners have since worked to customize the pump, which has been sold in Europe since 2016, for the U.S. market. Ypsomed plans to push ahead with the U.S. expansion without Lilly, outlining plans to file with the Food and Drug Administration in the second half of next year and commercialize the pump with a new partner. This is the second pump partner Lilly has dropped. They had a prototype with a company called DEKA but quietly disbanded that partnership a few years ago. https://www.medtechdive.com/news/lilly-LLY-ypsomed-insulin-pump-split/638492/ XX New more aggressive targets for blood pressure and lipids are among the changes to the annual American Diabetes Association (ADA) Standards of Care in Diabetes. The document, long considered the gold standard for care of the more than 100 million Americans living with diabetes and prediabetes, was published December 12 "In this year's version of the ADA Standards of Care — the longstanding guidelines for diabetes management globally — you'll see information that really speaks to how we can more aggressively treat diabetes and reduce complications in a variety of different ways," ADA Chief Scientific and Medical Officer Robert A. Gabbay, MD, PhD, told Medscape Medical News. Other changes for 2023 include a new emphasis on weight loss as a goal of therapy for type 2 diabetes; guidance for screening and assessing peripheral arterial disease in an effort to prevent amputations; use of finerenone in people with diabetes and chronic kidney disease; use of approved point-of-care A1c tests; and guidance on screening for food insecurity, along with an elevated role for community health workers. https://www.medscape.com/viewarticle/985482 XX I love this story.. A new report says eating a diet rich in vegetables may not reduce the risk of type 2 diabetes. Why? Because usually, potatoes are included a as veggie in these studies, including fried potatoes, potato chips, and mashed potatoes increase the risk. In the study, participants who consumed the most vegetables — minus potatoes — had a 21% reduced risk of diabetes than those without substantial amounts of vegetables in their diet. The vegetable most closely associated with a reduction in diabetes risk were green leafy vegetables and cruciferous vegetables. The new study assessed the effects of both vegetables and potatoes separately. They concluded that potatoes' neutral — or even negative effect — on diabetes had masked the true benefit of vegetable consumption. https://www.medicalnewstoday.com/articles/potatoes-and-diabetes-risk-cooking-method-matters XX Back to the news in a moment but first.. The T1D Exchange Registry is a research study conducted online over time, designed to foster innovation and improve the lives of people with T1D. The platform is open to both adults and children with T1D living in the U.S. Personal information remains confidential and participation is fully voluntary. Once enrolled, participants will complete annual surveys and have the opportunity to sign up for other studies on specific topics related to T1D. The registry aims to improve knowledge of T1D, accelerate the discovery and development of new treatments and technologies, and generate evidence to support policy or insurance changes that help the T1D community. By sharing opinions, experiences and data, patients can help advance meaningful T1D treatment, care and policy. The registry is now available on the T1D Exchange website and is simple to navigate, mobile and user-friendly. For more information or to register, go to www.t1dregistry.org/stacey XX The U.S. Food and Drug Administration has approved the first pill to improve control of diabetes in some cats. The drug called Bexacat (bexagliflozin tablets), is not insulin and is not meant for cats who have the type of diabetes that requires treatment with insulin. Rather, it is what is called a sodium-glucose cotransporter 2 (SGLT2) inhibitor. As part of the approval, the FDA requires that Bexacat labels include a boxed warning about the importance of patient selection. Only certain cats should take the drug, determined through careful screening. Bexacat also shouldn't be used in cats who are being treated with insulin or in those who have previously been treated with insulin. Typically cats with diabetes are treated with diet and insulin therapy, including twice-daily injections given 12 hours apart. https://www.usnews.com/news/health-news/articles/2022-12-09/cats-now-have-an-fda-approved-pill-to-treat-their-diabetes XX XX On the podcast next week.. yale lacrosse player Bri Carrasquillo was diagnosed just after her freshman year. Now she's part of Dexcom U – a new program for college athletes with type 1. Last week's show was G7 with Dexcom's Jake Leach Listen wherever you get your podcasts That's In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.
Ryan Hooey from the Accessible Insulin Pump Taskforce tells us about his petition to make pumps inclusive to people with vision loss. From the November 24, 2022 episode.
Full Videos - youtube.com/amithejerk?sub_confirmation=1 instagram.com/amithejerk Learn more about your ad choices. Visit megaphone.fm/adchoices
Full Videos - youtube.com/amithejerk?sub_confirmation=1 instagram.com/amithejerk
Iron Woman Diane has completed three full Ironman triathlons, numerous marathons and many cycling events, such as the New England Tour De Cure where My Body Odyssey first met her. One day, though, Diane drinks some juice before a yoga class and “next thing you know I'm inside an ambulance.” Maintaining healthy blood sugar levels is a balancing act for many millions of Americans with diabetes, especially those with Type 1 or juvenile diabetes, like Diane. This episode features expert commentary from Dr. Michael Riddell of York University, one of the world's true experts on diabetes and exercise, who also advises world class athletes like the NHL's Max Domi on diabetes management. If Maxi Domi routinely handles the intensity of pro hockey shifts, and Diane has conquered 13-hour triathlons, how did a simple yoga class land her in the emergency room? Listen in to find out on “Iron Woman Diane: The Rewards & Challenges of Exercise With Diabetes,” the second full episode of My Body Odyssey, a Fluent Knowledge production. Show Notes Our Experts: Dr. Michael Riddell, PhD: Faculty Page, Twitter, Google Scholar Dr. Riddell's laboratory Relevant Publications: Exercise management in type 1 diabetes: a consensus statement Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association More Resources: Diabetes Stats - CDC Cost Impact of Diabetes - CDC American Diabetes Association What is an Insulin Pump? American Cancer Society Tour De Cure New England Want to run an Ironman race? Why Coronavirus Is Dangerous For Diabetics Boston Marathon 2022 Yoga With Tim: The Total Body Yoga Workout Challenge Day 1 | Full Body Flow Max Domi Talks Living With Type 1 Diabetes Homepage: www.mybodyodyssey.com Follow us on: Twitter: @mybodyodyssey Facebook: @mybodyodysseypod Instagram: @mybodyodysseypodcast
Get ready, Jen is feeling CHATTY this week… there's an update on the many cuts and bruises she's collecting on her adventures, and with the extra stress of being immuno-compromised, she's turned to the carbs to get her through. Ami's got high hopes for a rom-com with a type 1 diabetes storyline, but she's slightly baffled as to how the main character manages to bag herself both an insulin pump AND a husband… Elsewhere Jen's lost an insulin pump to a vigorous suncream application, but she did fight off a snake at the same time (not exaggerating AT ALL…), and there was a mighty rollercoaster blood sugar day featuring a bowl of fruit and the new love of her life, Peloton. Just another low-key week with type 1 diabetes…Welcome to Type 1 on 1: The Diaries! Writer and broadcaster Jen Grieves and producer Ami Bennett are good friends - who both happen to live with type 1 diabetes. For this special spin-off series of Type 1 on 1, nana diabetic Jen (25 years) and baby diabetic Ami (3 years) chat through the frustrating, funny and challenging experiences they've faced each week thanks to this ridiculous condition. All in the hope that their stories might help you too.Thanks so much to Ypsomed MyLife Diabetescare for sponsoring this episode. https://www.mylife-diabetescare.com/en/Come and say hi on Instagram:https://www.instagram.com/missjengrieves/https://www.instagram.com/amilovesyoumore/
With all the new technological advancements in insulin pumps the leading supplier, Medtronic has gone from the top of the industry into the gutter with poorly designed products. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/michael-c-bouchard/message Support this podcast: https://anchor.fm/michael-c-bouchard/support
How does the act of care get designed into our everyday lives—beyond medical procedures and technology, into our relationships, our schedules, our lives? On this episode of The Futures Archive, Lee Moreau and Sara Hendren consider the insulin pump, and discuss what it might look like to think about a medical device in the context of all that's actually human. With additional insights from Jeff Bennett, Gianna Marzilli Ericson, Aaron Oppenheimer, and Christina Harrington.
Welcome to the Dark Fluff podcast! In this episode, I've got some juicy reddit stories for you... To watch my episodes in full, head to my YouTube channel: https://www.youtube.com/darkfluff Hosted on Acast. See acast.com/privacy for more information.
Jennifer tells PJ that kids were looking forward to new "smart" insulin pumps but a "pause" in handing them out means her kid could be facing 5 jabs a day. See acast.com/privacy for privacy and opt-out information.
In this episode, co-hosts Sami (type 1) and Dobie (type 2) discuss ‘Tech and Med Innovations' from the start of the time to today. It's everything you ever wanted to know aboutdiabetes innovations, but are too afraid to ask. I guess now you'll finally know which ‘Sir' created the first human insulin, but you'll have to listen to find out his entire name... Sami shares her experience with medical devices for the last nine years living with this disease, and Dobie discusses his initial thoughts on how to beat type 2 diabetes. Listen to hear what new devices are coming out and how diabetes care is rapidly advancing! C'est la vie, baby!Question of the pod: What's the tech innovation that has changed your life the most?Share it with us at:Instagram: @justmytypepod_Twitter: @justmytypepod_Tik Tok: @justmytypepod_Facebook: @justmytypepodHashtag: #justmytypepodThis episode of Just My Type is sponsored by ExpressionMed: A tape company that makes hundreds of designs for CGMs and other diabetic devices. Show off your style and save your skin with their vibrant & skin-safe tapes. Use code JMT15 at expressionmed.com to receive 15% off your first order.Just My Type has recently been mentioned as a top diabetes podcast, check out the list here: https://blog.feedspot.com/diabetes_podcasts/For more information and to listen to more episodes check out our website:www.justmytypepodcast.comDisclaimer Nothing expressed on the Just My Type podcast or on the Just My Type website is intended or should be interpreted or used as medical advice. You should always consult with a competent physician with respect to all aspects of your health and wellness.Ad Song: Just Smile by LiQWYD Creative Commons — Attribution 3.0 — CC BY 3.0
Insulin Pumps and CGMs can be life-changing--miraculous even. But as always-connected medical devices, that influence can be... complicated.These devices, and the many others used in treating Diabetes, leave physical traces behind that stay present for people as they go about their day-to-day life. Melissa and Steve talk through what it means that pumps and monitors have to be right there with you AT ALL TIMES (better have a bag ready). And what is more, they are attached to the skin and inserted into the body in ways that can leave marks, holes, and scars behind for days or even weeks/months.We also made banana bread! (Or... is it cake? Anyone care to chime in?) This recipe comes from Aubry Bennion (@aubryeliz on Instagram), and is super rich and indulgent -- plus super simple and is a great one to make with little ones.There's more! We also finally launched our website, diabreadic.com , where you can go to find more detailed information from our episodes along with more content related to Diabetes, chronic illness, bread and breadmaking, and much much more.Be sure to follow and/or subscribe wherever you are listening, and go find us on Instagram @diabreadic! While you're at it, head over to Apple Podcasts or Spotify and leave us a review.Music: September Rain by Yme Fresh https://bit.ly/yme-freshCreative Commons Attribution licenceFree Download / Stream: https://bit.ly/3FfoBtAMusic promoted by Audio Library https://youtu.be/kVCTa0-bDkQ
Imagine a future where diabetes is the last thing on the mind of people living with it – that is progress! In part #1 we got an inside look at how the insulin industry is spurring each other on to make advancements in diabetes management. In part #2 we continue the conversation with the leaders […]
Everybody has an opinion about the best way for you to manage T1D. Your doctor may think a pump is the only way to go. Your friends with T1D might swear by using multiple daily injections (MDI). Your insurance company wants to know what is going to be the most cost-effective option. Which option is best for you? And most importantly, which diabetes management option is best for your mental health? In this episode of The Diabetes Psychologist Podcast, I break down the mental health advantages and disadvantages of using an insulin pump and MDI. I talk about why making the best choice for you is so important and give you some things to consider as you work to make the decision that's right for you (at least for right now). Follow The Diabetes Psychologist on Instagram @thediabetespsychologist and join The Diabetes Psychologist Community on Facebook.
The world of diabetes management is growing at an expeditious rate, so how do we define progress in this space? Great question, and one I couldn’t resolve myself so I brought in past podcast guest and fellow T1D, Mark Carter, who has worked within the industry. We had the pleasure of sitting with three insulin pump therapy […]
Lauren Adams is a runner, marathoner, diabetes educator, and dietician with Type I Diabetes. She is also a member of the Diabetes Sports Project. Diabetes Sports Project (DSP) is an organization built to inspire. Led by a group of world class athletes who thrive with diabetes, their stories, athletic accomplishments and community outreach empower others to live healthy, responsible and active lives. Lauren recalls her journey starting as a high school and college track and cross country athlete managing the highs and lows of diabetes. Through the years, her persistence through education, technology, and training has helped her stay on top of her blood glucose management to one of the best marathons of her life. Resources:Blood Sugar Sensor, Insulin Pump, and Automation From Tandem Diabetes Carehttps://www.tandemdiabetes.comDiabetes Sports Project http://www.diabetessportsproject.comBooks:The Athlete's Guide to Diabetes by Sheri ColbergWaterlogged: The Serious Problem of Overhydration in Endurance Sports by Tim Noakes, MD, DScFor additional questions on today's topic, you can email us at coachograttan@gmail.com Run Coaching Services - www.TeamOcoaching.comYou can also find us on our social media accounts for more education and inspiration.Instagram: @teamocoaching | Facebook: teamocoachingSong: Lostboy & Slashtaq - Elysium [NCS Release]